Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/2281| Title: | Telehealth in oncology: A cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial. |
| Author: | Alexander, M. Collins, I. Abraham, P. Underhill, C. Harris, S. Torres, J. Sharma, Sharad Solomon, B. Tran-Duy, A. Burbury, K. |
| Issue Date: | 2023 |
| Publication Title: | Internal Medicine Journal |
| Volume: | 53 |
| Issue: | 12 |
| Start Page: | 2346 |
| End Page: | 2349 |
| Abstract: | This cost analysis, from a societal perspective, compared the cost difference of a networked teletrial model (NTTM) with four regional hubs versus conventional trial operation at a single metropolitan specialist centre. The Australian phase 3 cancer interventional randomised controlled trial included 152 of 328 regional participants (patient enrolment 2018–2021; 6-month primary end point). The NTTM significantly reduced (AU$2155 per patient) patient travel cost and time and lost productivity. |
| URI: | http://hdl.handle.net/11054/2281 |
| DOI: | https://doi.org/10.1111/imj.16292 |
| Internal ID Number: | 02393 |
| Health Subject: | COST ANALYSIS TELETRIAL PATIENT COST CANCER CLINICAL TRIAL |
| Type: | Journal Article Article |
| Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.